Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?
Kluth LA, Xylinas E, Rieken M, Chun FK, Fajkovic H, Becker A, Karakiewicz PI, Passoni N, Herman M, Lotan Y, Seitz C, Schramek P, Remzi M, Loidl W, Guillonneau B, Rouprêt M, Briganti A, Scherr DS, Graefen M, Tewari AK, Shariat SF. Kluth LA, et al. Among authors: xylinas e. Urol Oncol. 2014 Jan;32(1):47.e1-8. doi: 10.1016/j.urolonc.2013.06.013. Epub 2013 Sep 18. Urol Oncol. 2014. PMID: 24055425
Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
Rouprêt M, Hupertan V, Comperat E, Drouin SJ, Phé V, Xylinas E, Demanse D, Sibony M, Richard F, Cussenot O. Rouprêt M, et al. Among authors: xylinas e. BJU Int. 2009 Sep;104(6):813-7; discussion 817-8. doi: 10.1111/j.1464-410X.2009.08473.x. Epub 2009 Feb 27. BJU Int. 2009. PMID: 19254280
Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?
Ploussard G, Salomon L, Xylinas E, Allory Y, Vordos D, Hoznek A, Abbou CC, de la Taille A. Ploussard G, et al. Among authors: xylinas e. J Urol. 2010 Feb;183(2):539-44. doi: 10.1016/j.juro.2009.10.009. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006888 Free article.
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study.
Rouprêt M, Drouin SJ, Larré S, Neuzillet Y, Botto H, Hitier M, Rigaud J, Crew J, Xylinas E, Salomon L, Cornu JN, Iborra F, Champetier D, Rozet F, Flamand V, Bastide C, Cormier L, Durand X, Lunardi P, Rischmann P, Nouhaud FX, Ferlicot S, Patard JJ, Floch AP, Irani J, Peyronnet B, Bensalah K, Poissonnier L, Grès P, Droupy S, Casenave J, Wallerand H, Soulié M, Pfister C; Bladder Cancer Committee of the French National Association of Urology (“CC-AFU Vessie”). Rouprêt M, et al. Among authors: xylinas e. Ann Surg Oncol. 2011 Dec;18(13):3833-8. doi: 10.1245/s10434-011-1824-y. Epub 2011 Jun 7. Ann Surg Oncol. 2011. PMID: 21647762
Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguié M, Ruffion A, Rouprêt M; French Collaborative National Database on UUT-UC. Ouzzane A, et al. Among authors: xylinas e. Eur Urol. 2011 Dec;60(6):1258-65. doi: 10.1016/j.eururo.2011.05.049. Epub 2011 Jun 7. Eur Urol. 2011. PMID: 21665356
356 results